necrosis factor from murine macrophages. It was found that LAM from the avirulent H37Ra strain was 100-fold more potent at inducing tumor necrosis factor secretion than LAM from the virulent Erdman strain, thus leading us to hypothesize that the structure of LAM from a given mycobacterial isolate may directly influence its ability to elicit, or avoid, cytokine-mediated mechanisms of host resistance.
Tumor necrosis factor alpha (TNF) has been implicated in the regulation of immune responses to a wide range of infectious pathogens and in the mediation of the manifestations of disease caused by these organisms. Intravenous administration of TNF causes physiologic and metabolic derangements characteristic of septic shock due to infection with gram-negative bacteria (21) , and elevated levels of TNF in serum have been found with a number of infectious diseases, including human immunodeficiency virus infection, malaria, and leishmaniasis. In these infections, the highest concentrations of TNF have been found in sera of patients with more severe manifestations of disease, suggesting an immunopathologic role for this cytokine. On the other hand, TNF enhances microbicidal activity against bacteria such as Salmonella and Listeria species, fungi such as Torulopsis and Candida species, and protozoan parasites, indicating that TNF may be involved in host defenses against a wide variety of pathogens (8, 10, (18) (19) (20) .
TNF appears to have direct antimycobacterial properties and inhibits mycobacterial growth in vitro (2) . Studies with animals suggest that TNF may inhibit the extent of mycobacterial infection by mediating granuloma formation in vivo (13) . Elevated concentrations of TNF have been found in sera of patients with leprosy and in pleural fluids of patients with tuberculous pleuritis (1, 24) , suggesting a role for TNF in the human immune response against mycobacteria. In addition to eliminating organisms, TNF may contribute to the immunopathology of these diseases by causing fever, weight loss, and tissue necrosis (27, 28) .
A comprehensive understanding of the role of TNF in the pathogenesis of human infectious disease requires definition of the biochemical components of microbial pathogens which induce TNF release. In this respect, it is now known that mycobacteria contain their own lipopolysaccharides (LPS), lipoarabinomannan (LAM) and lipomannan (LM), with physical properties analogous to those of 0-antigenic LPS (3). There is now appreciable evidence that LAM can interact directly with cells of the immune system, thus possibly modifying the expression of acquired resistance to mycobacterial diseases. Such modifications may involve the inhibition of blastogenesis by T lymphocytes (12, 16) , probably as a result of the secretion of large amounts of TNF by * Corresponding author.
macrophages (1, 17, 28) , by interference with gamma interferon-mediated macrophage activation (25) , or indirectly by scavenging toxic oxygen intermediates produced by mycobacterium-infected host cells (4) .
We now report that in the course of examining the activity of LAMs from different mycobacteria to evoke TNF secretion by mouse mononuclear cells, a marked difference between avirulent (H37Ra) and virulent (Erdman) Mycobacterium tuberculosis was observed. This observation is discussed in the light of our recent delineation of marked structural differences in the nonreducing termini of LAMs from these two sources (5, 6) , as are speculations on the structural basis of the biological activity of LAM and on the basis of the capacity of mycobacterial strains to give rise to persistent disease within the infected host.
To prepare mycobacterial glycolipids, cultures of M. tuberculosis Erdman TMC 107 were grown for 6 to 8 weeks in glycerol-alanine salts medium, autoclaved, filtered, and washed. The bacterial cells (-100 g [wet weight]) were resuspended in phosphate-buffered saline containing 0.5% Triton X-100 and 0.02% NaN3 (200 ml) and sonicated; the sonicate was passed through a French pressure cell at 20,000 lb/in2. This material was then centrifuged at 27,000 x g for 45 min. Distilled acetone was added to the precooled supernatant to a final concentration of 90% acetone to precipitate LAM, LM, and PIM (phosphoinositolmannoside), which were collected by centrifugation and air dried. The dry acetone precipitate (1 g) was suspended in 6 M guanidine HCI in 10 mM Tris HCI, pH 7.4, by brief sonication and applied to a Sephacryl S-400 column (1.5 by 150 cm). Fractions were collected and monitored by polyacrylamide gel electrophoresis (PAGE). Final purification of LAM was achieved by applying a mixture of LAM, LM, and PIM to a Sephacryl S-200 column with a buffer (23) containing 10 mM Tris HCl (pH 8.0), 0.2 M NaCl, 0.5 M EDTA, and 0.25% deoxycholate. Fractions containing pure LAM, LM, and PIM, which were resolved at this stage, were pooled and dialyzed. To ensure that minimal LPS contamination was present in preparations, lyophilized LAM, LM, and PIM were redissolved in sterile, pyrogen-free water, filtered through a polytetrafluoroethylene filtration unit (pore size, 0.45 p,m), passed through a 2-ml Detoxi-Gel column (Pierce Chemical, Rockford, Ill.), and refiltered through a sterile filter (pore size, 0.20 p,m); the filtrate was collected into a sterile, pyrogen-free vial and dried. Levels of contaminating LPS endotoxin in stocks of LAM, LM, and PIM were determined by using a Limulus amebocyte lysate commercial assay (E-Toxate, Sigma kit no. 210; Sigma Chemical Co., St. Louis, Mo.).
Procedures for the purification of LAM, LM, and PIM from M. tuberculosis H37Ra, which predate the procedures described above, have been described previously (11) .
Experiments were performed with female C57BL/6 mice, 6 to 8 weeks old, which were purchased from the Jackson Laboratory, Bar Harbor, Maine. Peritoneal macrophages were harvested from animals inoculated intraperitoneally with 2 Following isolation, LAMs from the H37Ra and Erdman strains of M. tuberculosis were compared for the ability to induce TNF secretion from peritoneal or bone marrowderived macrophages (Fig. 2) . While LAMs from both strains elicited TNF release in a dose-dependent manner, approximately 100-fold more of the Erdman-derived LAM was required to evoke levels of TNF secretion similar to those induced by H37Ra LAM, regardless of the type of macrophage studied. In further experiments, the intact H37Ra LAM was compared with purified LM, PIM, and deacylated LAM from the same strain (Fig. 3) . All three materials showed a substantially reduced capacity to induce TNF secretion. Indeed, the levels of TNF activity produced by these materials were comparable to that of Erdman LAM. Loss of function following deacylation of LAM has been noted previously (16) .
In a final series of experiments, a variety of controls was run to exclude the possibility that the observations described above could not be fully or partially explained by contamination of the LAM preparations by LPS endotoxin. In (Fig. 4B) , LAM was cocultured in the presence of two LPS inhibitors, polymyxin B and diphosphoryl lipid A. Neither material significantly inhibited the capacity of LAM to elicit TNF secretion.
In a second series of control experiments, bone marrowderived macrophages from an LPS-responsive mouse strain (C3H/HeN) were compared with those from an LPS-nonresponsive strain (C3H/HeJ). In both cases, it was reproducibly observed that LAM elicited TNF secretion while LPS did not (Fig. 5) . A noticeable finding, however, was that the LPS-nonresponsive strain (C3H/HeJ) macrophages were poorly responsive, eliciting only about 0.6 to 0.9 ng of TNF per ml in various experiments when stimulated with 100 ,ug of LAM per ml. This finding may suggest strain variations in the response of mouse macrophages to LAM; this possibility is currently under investigation.
Thus, the results of this study demonstrate a surprising relationship between the structures of the nonreducing terminal regions of LAMs, recently elucidated in this laboratory (5, 6) , and the capacity of LAMs to elicit TNF secretion by macrophages. Simply stated, LAM from the avirulent H37Ra strain of M. tuberculosis, characterized as it is by extensive arabinan side chains (5), was extremely potent at inducing TNF secretion, even at very low concentrations in vitro. In contrast, LAM from the virulent Erdman strain, in which the arabinan side chains were recently found to be extensively masked by short mannan segments (6) , had approximately 100-fold less activity. LM and PIM devoid of arabinose showed consistency in eliciting low levels of TNF release similar to those induced by the Erdman LAM. These results are surprising in that upon discovery that LAM and LM were prokaryote versions of the important family of glycosylphosphatidyl inositols, we had predicted that biological activity would be attributable to the presence of a phosphatidyl inositol "membrane anchor" (15) . Thus, the paradigm of the glycosylphosphatidyl inositols seems not to apply to LAM. These findings also have other implications. The first is that the capacity of the LAM possessed by a given strain of M. tuberculosis to elicit TNF secretion by the infected macrophage may directly influence the subsequent ability of the organism to survive and replicate within the host. Accordingly, it is possible that the H37Ra strain, which does not replicate in infected animals and which at best may give rise to a low-level chronic disease state (7) , is unable to generate a productive infection because LAM rapidly triggers the release of TNF (and probably other cytokines) from the infected macrophages. As a result, these infected cells may acquire enhanced bacteriostatic activity, and other mononuclear phagocytes may accumulate, resulting in rapid granuloma formation. In this regard, the role of TNF in the recruitment and formation of such granulomas is now well established (13) .
In contrast, the lesser potency of the LAM from the Erdman strain to elicit TNF activity may be central to the ability of this particular organism to proliferate in an unrestrained manner within infected host macrophages prior to the subsequent generation of T-cell-mediated immunity (22) . If this hypothesis is correct, the precise structure of the LAM from a given mycobacterial species may directly influence the capacity of the organism to survive and give rise to active infection. In addition, it is possible that the expression of terminal mannose units which effectively mask the biologically active arabinan side chains within the Erdman LAM structure may reflect an adaptive evolutionary change which may allow the organism to survive within the infected host. Such an adaptation may also be regarded as a form of molecular mimicry, given the structural similarity to the mannose-rich segments of many mammalian glycoproteins (14) .
With regard to the precise nature of the interaction of the LAM molecule with the macrophage cell surface, there is currently no information in the literature to suggest that macrophages possess receptors that specifically bind arabinose and hence could explain the potent ability of the H37Ra LAM to trigger TNF secretion in a specific manner by such cells. In contrast, it is well established that these cells possess a mannose receptor (29) . This receptor has been structurally defined and has been found to be a complex molecule in that there are at least eight protein regins formed into domains by disulfide bonding within the overall molecule in which carbohydrate can be bound (9). It is therefore theoretically possible that the receptor can be promiscuous and bind ligands other than mannoses. Which ligands are bound and the number of domains occupied may influence the type of signaling transmitted into the cell itself and hence may influence the physiological response of the cell in terms of secretion of various mediators.
Finally, it is intriguing that recent structural information and recent evidence of the biological activity of mycobacterial LAM, when viewed collectively, indicate that biological functions of LAM are endowed at both ends of the molecule. Thus, as shown above, masking of arabinose terminal units by mannose dramatically reduces the biological activity of LAM. However, a similar loss of activity can also be obtained by the removal of fatty acyl groups associated with the phosphoinositol core of the LAM molecule, as shown here and elsewhere (17 
